#USA #Wilmington #Medical Device #TMRW Vault #ReproTech

TMRW Vault® Achieves CE Mark Certification

In a significant achievement for the field of reproductive medicine, Reprotech has announced that its TMRW Vault® has received the CE mark indicating it meets the regulatory standards for medical devices in Europe. Classified as a Class IIa medical device under the EU Regulation 2017/745, this certification will enhance the product's marketability in the European Union and other international markets where CE marking is recognized.

A New Era in Reproductive Medicine

The TMRW Vault is not just another medical device; it is a groundbreaking innovation that combines advanced cryopreservation techniques with modern tracking solutions. This state-of-the-art digital repository is specifically designed for fertility clinics to store reproductive samples including eggs, embryos, and sperm in liquid nitrogen. By providing robust sample identification and traceability features, the TMRW Vault aims to minimize risks associated with sample handling, while promoting operational efficiencies in clinics.

Features of TMRW Vault

The TMRW Vault Freezer is engineered to optimize storage of reproductive samples, addressing an increasing demand for secure and scalable preservation solutions in fertility clinics. Historically, many clinics have relied on manual storage systems, leading to operational inefficiencies and a heightened risk for human error. The TMRW Vault implements a sophisticated onsite cryopreservation infrastructure integrated with TMRW's proprietary ivfOS software platform, thereby modernizing the sample management process. Here are some key features that stand out:

• - RFID-enabled CryoBeacons for digital verification of sample identity and location.
• - Manual Access to a technology-enhanced vault-tank, enabling embryologists to efficiently manage sample storage and retrieval without compromising traceability.
• - Advanced Monitoring through TMRW Overwatch® which performs thousands of system checks daily, supported by expert oversight.
• - Scalable Storage Capacity, with a single vault-tank capable of holding as much as ten conventional Dewar containers while occupying about a third of the floor space.
• - Seamless Integration with the wider TMRW ecosystem and external cryopreservation services, ensuring smooth connectivity and functionality.
• - Easy Installation, enabling clinics to implement the system quickly with minimal disruption to their day-to-day operations.

Background and Future Prospects

This announcement follows the corporate merger between Reprotech and TMRW Life Sciences in April 2026, which combined decades of cryopreservation experience with next-generation digital technologies. With the additional acquisition of IMT Matcher in June 2025, the new organization aims to offer clinics one of the most comprehensive ecosystems for electronic sample verification, digital traceability, onsite and external cryopreservation, consent management, and inventory control.

Reprotech stands as the market leader in providing solutions for the protection, management, and long-term storage of reproductive samples. Their consolidated portfolio includes seven specially designed biorepositories, cutting-edge cryopreservation management technologies, and global digital solutions designed to create a seamless tracking chain.

Building on their extensive experience and driven by continuous innovation, Reprotech sets the industry standard for protecting samples from clinic to cryopreservation and back, ensuring that clients have secure means to preserve what is most critical today and in the future. To learn more about their initiatives and products, visit Reprotech's website.

Media Contact: Sarah Roberts, Email: [email protected]